home > ict > summer 2011 > data dynamics


Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.


News and Press Releases

Vaccizone Selects Exothera for Process Development and GMP Manufacturing of its SARS CoV 2 Vaccine Based on Proprietary ASC Technology

Istanbul, Turkey, 6 July 2022: Life Science Newswire Vaccizone, a vaccine development company focusing on innovative antigen delivery technology, selected Exothera S.A. to fast-track process development of its SARS CoV 2 vaccine for European clinical trials.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement